| Product Code: ETC7744146 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Oncology Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Oncology Market - Industry Life Cycle |
3.4 Japan Oncology Market - Porter's Five Forces |
3.5 Japan Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Japan Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Japan Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Technological advancements in oncology treatments |
4.2.3 Growing investment in research and development in the oncology sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for oncology drugs |
4.3.2 High costs associated with oncology treatments |
4.3.3 Limited access to advanced oncology care in rural areas |
5 Japan Oncology Market Trends |
6 Japan Oncology Market, By Types |
6.1 Japan Oncology Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Oncology Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Japan Oncology Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.4 Japan Oncology Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.1.5 Japan Oncology Market Revenues & Volume, By Colon & rectal cancer, 2021- 2031F |
6.1.6 Japan Oncology Market Revenues & Volume, By Gastric cancer, 2021- 2031F |
6.1.7 Japan Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Oncology Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 Japan Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Japan Oncology Market Revenues & Volume, By Diagnostic laboratories, 2021- 2031F |
6.2.4 Japan Oncology Market Revenues & Volume, By Diagnostic imaging centers, 2021- 2031F |
6.2.5 Japan Oncology Market Revenues & Volume, By Academia, 2021- 2031F |
6.2.6 Japan Oncology Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.2.7 Japan Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Oncology Market Import-Export Trade Statistics |
7.1 Japan Oncology Market Export to Major Countries |
7.2 Japan Oncology Market Imports from Major Countries |
8 Japan Oncology Market Key Performance Indicators |
8.1 Patient survival rates after treatment |
8.2 Adoption rate of innovative oncology therapies |
8.3 Rate of successful clinical trials for new oncology treatments |
9 Japan Oncology Market - Opportunity Assessment |
9.1 Japan Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Japan Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Japan Oncology Market - Competitive Landscape |
10.1 Japan Oncology Market Revenue Share, By Companies, 2024 |
10.2 Japan Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here